Therapeutic potential of cyanobacterial pigment protein phycoerythrin: in silico and in vitro study of BACE1 interaction and in vivo Aβ reduction
- 1 August 2019
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 134, 368-378
Abstract
No abstract availableKeywords
Funding Information
- SERB
- Department of Science and Technology, Ministry of Science and Technology (SB/YS/LS-290/2013, YSS/2015/000086)
- SERB (SB/YS/LS-290/2013)
This publication has 48 references indexed in Scilit:
- Effect of plant extracts on Alzheimer’s disease: An insight into therapeutic avenuesJournal of Neurosciences in Rural Practice, 2011
- Biotechnological and industrial significance of cyanobacterial secondary metabolitesBiotechnology Advances, 2009
- Protein quality in bacterial inclusion bodiesTrends in Biotechnology, 2006
- Amyloid fibril proteinsMechanisms of Ageing and Development, 2002
- Crystal Structure of Memapsin 2 (β-Secretase) in Complex with an Inhibitor OM00-3Biochemistry, 2002
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Substrate and Inhibitor Profile of BACE (β-Secretase) and Comparison with Other Mammalian Aspartic ProteasesJournal of Biological Chemistry, 2002
- Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with InhibitorScience, 2000
- Proteolytic Activation of Recombinant Pro-memapsin 2 (Pro-β-secretase) Studied with New Fluorogenic SubstratesBiochemistry, 2000
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999